Mark O’Sullivan
Royal Children's Hospital
16 Papers
106 Citations
Mark O’Sullivan is an academic researcher from Royal Children's Hospital. The author has contributed to research in topics: Medicine & Reduction (orthopedic surgery). The author has an hindex of 8, co-authored 11 publications.
Chat about Author
Papers
Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome
TL;DR: Pamidronate treatment is an effective therapeutic modality for children with polyostotic fibrous Dysplasia, with a good short-term safety profile, and failure to demonstrate major biochemical or bone densitometry improvements is due to the nature of the fibrous dysplasia and intercurrent microfracture.
83
Intramedullary rodding and bisphosphonate treatment of polyostotic fibrous dysplasia associated with the McCune-Albright syndrome.
TL;DR: This treatment was successful in all patients, as judged by improvement in their quality of life and in clinical parameters, such as decreased bone pain and fracture rate, and improved walking ability.
57
Which implant for proximal femoral osteotomy in children? A comparison of the AO (ASIF) 90 degree fixed-angle blade plate and the Richards intermediate hip screw.
TL;DR: Both AO (ASIF) 90 degree fixed-angle blade plate and Richards intermediate hip screw were effective with an acceptable rate of complications and revision surgery.
55
Ligamentum Teres Tenodesis in Medial Approach Open Reduction for Developmental Dislocation of the Hip
Christopher Edward Bache,H Kerr Graham,D Robert V Dickens,Leo Donnan,Michael Johnson,Gary Nattrass,Mark O’Sullivan,Ian P. Torode +7 more
TL;DR: It is demonstrated that it is possible to use a medial approach for open reduction of the congenitally dislocated hip in combination with tenodesis of the ligamentum teres to the anteromedial joint capsule and the many advantages of open reduction by the medial approach outweigh the disadvantages.
43
Successful treatment of a sacral aneurysmal bone cyst with zoledronic acid.
TL;DR: It is concluded that bisphosphonates should be considered as possible second-line agents for ABCs, with rapid reduction in pain and resolution of previously severe immobility, from being bed and chair bound at baseline to normal independent ambulation over several months.
26